| Dr Gail Alicia Kirkland-briscoe, DDS | |
|
3012 18th St Ne, Washington, DC 20018-2458 | |
| (202) 526-4060 | |
| (202) 526-4065 |
| Full Name | Dr Gail Alicia Kirkland-briscoe |
|---|---|
| Gender | Female |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 3012 18th St Ne, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114041183 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | DEN4726 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gail Alicia Kirkland-briscoe, DDS 3012 18th St Ne, Washington, DC 20018-2458 Ph: (202) 526-4060 | Dr Gail Alicia Kirkland-briscoe, DDS 3012 18th St Ne, Washington, DC 20018-2458 Ph: (202) 526-4060 |
News Archive
According to a year-long study of 644 children aged between 7 and 11 in six primary schools in Christchurch, England – outlined this week on the website of the British Medical Journal – a one-year campaign to curb soft drink intake led to a decrease in the percentage of those children who were overweight or obese.
Glioblastoma multiforme is among the most lethal of cancers and the most stubborn in the face of treatment. Fewer than 20 percent of patients survive more than two years after diagnosis, according to the Central Brain Tumor Registry of the United States.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
Pharmacyclics, Inc. today announced that The New England Journal of Medicine published results of a Phase 2 study evaluating the investigational oral Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed/refractory mantle cell lymphoma online.
› Verified 2 days ago
Dr. Hassan E Chehayeb, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4201 Massachusetts Ave Nw, 1040c, Washington, DC 20016 Phone: 202-244-3902 Fax: 202-244-6547 | |
Dr. Siamak Sy Majidi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3239 N St Nw Apt 12, Washington, DC 20007 Phone: 240-418-6103 | |
Dr. Cecile Elaine Skinner, DDS., PH.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 600 W St Nw, Washington, DC 20059 Phone: 202-806-0462 Fax: 202-806-0303 | |
Tomell Lemart Dubose, Dentist Medicare: Not Enrolled in Medicare Practice Location: 5437 Connecticut Ave Nw, 203, Washington, DC 20015 Phone: 202-364-6550 Fax: 202-364-7297 | |
Dr. Dominicque Blanche Gray, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3946 Minnesota Ave Ne, Washington, DC 20019 Phone: 202-397-1033 | |
Dr. Manasi Supekar, Dentist Medicare: Medicare Enrolled Practice Location: 3521 12th St Ne, Washington, DC 20017 Phone: 020-245-0592 | |
Dr. Chi-lan Pham, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 4200 Wisconsin Ave Nw Ste 240, Washington, DC 20016 Phone: 202-545-7200 |